Amazon is terminating its contract with Progyny, a company that sells fertility benefits such as in vitro fertilization and egg freezing to employers, according to a source familiar with the matter.
Starting Jan. 1, 2025, Amazon employees will no longer have access to Progyny’s services. Instead, Amazon will use Maven as its fertility benefits vendor, the person said. Amazon already had a relationship with Maven for virtual “family-building care.” The person asked not to be identified because Amazon is still communicating the change to its workers.
On Wednesday, Progyny disclosed to investors that a “significant client” had decided to end its agreement with the company. Progyny did not name the client, but said the client had 670,000 members and represented 13% of Progyny’s revenue in 2023. The company said the client accounted for a “smaller percentage” of its profits.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
